Influence of smoking on the survival rate of diabetic patients requiring hemodialysis

Diabetes Care

Volumn 19, Issue 6, 1996, Pages 625-628

  Biesenbach, Georg ^a   Zazgornik, Jan ^a  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; GLYCOSYLATED HEMOGLOBIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; DIABETIC NEPHROPATHY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; LIPID BLOOD LEVEL; MALE; PROGNOSIS; RISK FACTOR; SMOKING; SURVIVAL TIME;

EID: 0029954212     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.6.625     Document Type: Article

References (29)

1. Biesenbach G, Janko O, Zazgornik J: Similar rate of progression in the pre-dialysis phase in type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant 9:1097-1102, 1994
2. Chase HP, Garg SK, Marshall G, Berg CL, Harris S, Jackson WE, Hamman RE: Cigarette smoking increases the risk of albuminuria among subjects with type 1 diabetes. JAMA 265:614-617, 1991
3. Mühlhauser I, Sawicki P, Berger M: Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in type 1 (insulin-dependent) diabetes. Diabetologia 29:500-502, 1986
4. Couper JJ, Staples AJ, Cocciolone R, Nairn J, Badcock N, Henning P: Relationship of smoking and albuminuria in children with insulin-dependent diabetes. Diabetic Med 11:666-669, 1994
5. Mühlhauser I: Cigarette smoking and diabetes: an update. Diabetic Med 11:336-343, 1994
6. West KM, Endreich LS, Stober JA: Absence of relationship between smoking and diabetic microangiopathy. Diabetes Care 3:250-252, 1980
7. Stegmayr BG: A study of patients with diabetes mellitus (type 1) and end-stage renal failure: tobacco usage may increase risk of nephropathy and death. J Intern Med 228:121-124, 1990
8. World Health Organization: Cardiovascular Survey Methods. Geneva, World Health Org., 1968 (monogr. ser. no. 56)
9. Christiansen JS: Cigarette-smoking and prevalence of microangiopathy in juvenile onset insulin-dependent diabetes mellitus. Diabetes Care 1:146-149, 1978
10. Ekberg G, Grefberg N, Larsson LO, Vaara I: Cigarette smoking and glomerulus filtration rate in insulin-treated diabetics without nephropathy. J Intern Med 228: 211-117, 1990
11. Norden G, Nyberg G: Smoking and diabetic nephropathy. Acta Med Scand 215: 257-261, 1984
12. Stegmayr BG: Tobacco and end stage diabetic nephropathy. Br Med J 295:581-581, 1987
13. Eadington DW, Patrick AW, Collier A, Frier BM: Limited joint mobility, Dupuytren's contracture and retinopathy in type 1 diabetes; association with cigarette smoking. Diabetic Med 6:152-157, 1989
14. Moss SE, Klein R, Klein BEK: Association of cigarette smoking with diabetic retinopathy. Diabetes Care 14:119-126, 1991
15. Paetkau ME, Boyd TAS, Winship B, Grace M: Cigarette smoking and diabetic retinopathy. Diabetes 26:46-49, 1977
16. Telmer S, Christiansen JS, Andersen AR, Nerup R, Decken T: Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Med Scand 215:257-261, 1984
17. Mitchell BD, Hawthorne VM, Vinik AI: Cigarette smoking and neuropathy in diabetic patients. Diabetes Care 134:434-437, 1990
18. Banga JD, Sixma JJ: Diabetes mellitus, vascular disease and thrombosis. Clin Haematol 15:465-492, 1986
19. Di Minno G, Silver MJ, Carbone AM, Riccardi G, Rivellese A, Maucinin M, Thiagarajan P: Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane. Blood 65:156-159, 1985
20. Knuiman MW, Welborn TA, MaCann VJ, Stauton KG, Constable IJ: Prevalence of diabetic complications in relation to risk factors. Diabetes 35:1332-1336, 1986
21. Mancia G, FitzGerald GA: Proceedings of the symposium on smoking: a risk factor for cardiovascular disease. Am Heart J 115 (Suppl. 1):240-296, 1988
22. Nilsson TK, Lithner F: Glycaemic control, smoking habits and diabetes duration affect the extrinsic fibrinolytic system in type 1 diabetic patients but microangiopathy does not. Acta Med Scand 224:123-129, 1988
23. Wilkes HC, Kelleher C, Medade TW: Smoking and plasma fibrinogen. Lancet i:307-308, 1988
24. Wald N, Howard S, Smith PG, Kjeldsen K: Association between atherosclerotic diseases and carboxyhaemoglobin levels in tobacco smokers. Br Med J 1:761-765, 1973
25. Biesenbach G, Quadlbauer G, Zazgornik J: Cigarette-smoking as an additional risk factor for development of diabetic micro- and macroangiopathy in type 1-diabetes. Inn Med 16:157-160, 1989
26. Frestone S, Ramsay LE: Effect of coffee and cigarette smoking on the blood pressure of untreated and diuretic-treated hypertensive patients. Am J Med 73:348-353, 1982
27. Paterson AD, Dornan TL, Peacock I, Burden RP, Morgan AG, Tatersall RB: Causes of death in diabetic patients with impaired renal function. Lancet i:313-316, 1987
28. Fujimoto WY, Leonetti DL, Bergström RW, Shuman WP, Wahl PW: Cigaretie smoking, adiposity, non-insulin-dependent diabetes, and coronary heart disease in Japanese-American men. Am J Med 89: 761-771, 1990
29. Brand FN, Abbott RD, Kannel WB: Diabetes, intermittent claudication, and risk of cardiovascular events: the Framingham study. Diabetes 3:504-509, 1989